Day: July 15, 2025

iNKT cells uniquely remodel the tumor microenvironment, overcome immune resistance, and enable scalable off-the-shelf cell therapy NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies, today announced the publication of a peer-reviewed article titled “CAR-iNKT Cells: Redefining the Frontiers of Cellular Immunotherapy” in Frontiers in Immunology. The publication, authored by leading experts in iNKT biology, underscores the power of iNKT cells as the next-generation off-the-shelf platform for treating solid tumors—where conventional cell therapies have failed to deliver lasting results. “This publication highlights what sets MiNK apart,” said Jennifer Buell, PhD, President and CEO of MiNK...

Reno, Nev., July 15, 2025 (GLOBE NEWSWIRE) —American Battery Technology Company (ABTC) awarded $1M U.S. Department of Energy collaborative agreement to support new partnership project with Argonne National Laboratory, with use of their Advanced Photon Source particle accelerator and Aurora Exascale Supercomputer ABTC’s internally-developed advanced lithium processing technology can manufacture critical mineral lithium hydroxide with substantial reduction in use of chemical agents, at lower operational costs, and with lower impact New agreement is one of several current partnership agreements with American U.S. Department of Energy National Laboratories demonstrating the company’s commitment to advance the country’s acquisition of domestically sourced battery metals to ensure sustainable energy security American Battery...

HAUPPAUGE, N.Y., July 15, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the critical role its cryogenic Low Noise Amplifiers (LNAs) are playing in enabling the next generation of quantum computing—technology that is rapidly evolving to overcome the limitations of traditional silicon-based computing and fueling the rise of AI beyond classical boundaries. Quantum computers represent the cutting edge of computational science, capable of solving problems that would take classical supercomputers millions of years....

Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Nasdaq Hearing Panel has granted its request for an exception to complete its compliance plan, allowing the Company to maintain its listing on the Nasdaq Stock Market. Following a comprehensive review of IMUNON’s strategies to regain compliance, the Nasdaq Hearing Panel stated that IMUNON has already achieved compliance with the Equity Rule through recent fundraising activities. To ensure sustained compliance with the minimum shareholder equity requirement and to regain compliance with the minimum bid price requirement, the Company will implement...

KISSIMMEE, Fla., July 15, 2025 (GLOBE NEWSWIRE) — There are Land Rovers, and then there is Project Wilder, a hand-crafted California Land Rover Station Wagon by ECD Automotive Design with subtle styling cues from original series Land Rovers and later Land Rover Defenders, purpose-built to rule every road and outmatch every expectation. Conceived under California skies and brought to life in ECD’s Rover Dome, Project Wilder is more than a custom vehicle, it’s an untamed, 700+ horsepower thrill ride and ECD’s most powerful off-road build to date. View video of Project Wilder View images of Project Wilder From the outside, Project Wilder strikes a presence that is simultaneously classic and ferocious. Cloaked in Eastnor Green eggshell paint with subtle Nara Bronze accents, it pays tribute to heritage. Its 20-inch Kahn Mondial Retro...

Vancouver, Canada, July 15, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the expansion of its Phase I/IIa clinical trial for CMND-100, its proprietary MEAI-based oral treatment candidate for Alcohol Use Disorder (AUD), with the activation of additional site at Johns Hopkins University School of Medicine and the enrollment of the first participant at this clinical site. The trial is designed to evaluate the safety, tolerability, and pharmacokinetic profile of CMND-100, with preliminary efficacy indicators assessing its potential to reduce alcohol cravings and consumption. This expansion...

Q2 2025 Financial Results Expected to Exceed High End of Guidance Ranges MINNEAPOLIS, July 15, 2025 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced a strategic reinvestment plan to help drive long-term growth, improve operational efficiency and enhance shareholder value. Jamf’s recent comprehensive systems update, spanning both front- and back-office operations, has provided enhanced insights into Jamf’s business and growth opportunities. As a result, Jamf is embarking on a strategic reinvestment plan to support the continued success of the business. This plan includes strategic reallocation of resources to allow for investment in areas with the highest potential to fuel growth and drive additional operational leverage in the business. Two key focus areas are: 1. Go-To-Market...